PBG Research

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

PBG Cannabis

Feb 283 min read

PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression

VANCOUVER, British Columbia, February 27, 2024 – PBG BioPharma Inc. (PBG), a leading phytochemical biopharmaceutical company specializing...

Dan Jin published in Frontiers in Plant Science

PBG Cannabis

Jul 4, 20211 min read

Dan Jin published in Frontiers in Plant Science

Congratulations again to our Research Scientist Dan Jin for publishing a new cannabis research paper in the leading science journal...

Dr. Dan Jin

Jun 28, 20211 min read

Dan Jin Published in PLOS ONE

Congratulations to our Research Scientist Dan Jin for publishing a new cannabis research paper on influential and high-impact...

Friedelin in Cannabis Roots - Anti-Inflammatory, Antioxidant, and Liver Protective

Dr. Dan Jin

Apr 15, 20212 min read

Friedelin in Cannabis Roots - Anti-Inflammatory, Antioxidant, and Liver Protective

According to a recent study [1] by research scientists at PBG BioPharma, friedelin is the most prominent triterpenoid in cannabis, a...

Genetic Markers show Diversity, Population Structure, and Functional Basis Of Cultivated NA Cannabis

Dr. Dan Jin

Apr 1, 20211 min read

Genetic Markers show Diversity, Population Structure, and Functional Basis Of Cultivated NA Cannabis

A recent study by scientists from PBG BioPharma and Egret Bioscience have classified 420 cannabis accessions into five clusters (K1-K4...

Cannabis Strains with Wide Leaflets are Less Resistance to Fungal Infection

Dr. Dan Jin

Mar 31, 20211 min read

Cannabis Strains with Wide Leaflets are Less Resistance to Fungal Infection

A recent cannabis phenotyping study conducted by scientists in PBG BioPharma showed that cannabis strains with wide leaflets are less...

Three cannabis chemotypes differentiated at genome level

Dr. Dan Jin

Mar 23, 20211 min read

Three cannabis chemotypes differentiated at genome level

PBG BioPharma has launched a series of studies under Health Canada approved cannabis research license, proposing that a new...

PBG BioPharma actively developing cannabis-based products against SARS-CoV-2

Dr. Dan Jin

Mar 23, 20211 min read

PBG BioPharma actively developing cannabis-based products against SARS-CoV-2

The COVID-19 pandemic has had broad global ramifications and, while vaccine development is progressing, supplemental or alternative...

PARTNER WITH US

Got a project?
Let’s talk.

We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision.

Nutritional Supplements white label manufacturing - PBG